106 related articles for article (PubMed ID: 27636373)
1. The emerging role of serum/glucocorticoid-regulated kinases in cancer.
Castel P; Scaltriti M
Cell Cycle; 2017 Jan; 16(1):5-6. PubMed ID: 27636373
[No Abstract] [Full Text] [Related]
2. PDK1-SGK1 Signaling Sustains AKT-Independent mTORC1 Activation and Confers Resistance to PI3Kα Inhibition.
Castel P; Ellis H; Bago R; Toska E; Razavi P; Carmona FJ; Kannan S; Verma CS; Dickler M; Chandarlapaty S; Brogi E; Alessi DR; Baselga J; Scaltriti M
Cancer Cell; 2016 Aug; 30(2):229-242. PubMed ID: 27451907
[TBL] [Abstract][Full Text] [Related]
3. mTOR and Akt signaling in cancer: SGK cycles in.
Toker A
Mol Cell; 2008 Jul; 31(1):6-8. PubMed ID: 18614042
[TBL] [Abstract][Full Text] [Related]
4. Activation of SGK1 in Endometrial Epithelial Cells in Response to PI3K/AKT Inhibition Impairs Embryo Implantation.
Salker MS; Steel JH; Hosseinzadeh Z; Nautiyal J; Webster Z; Singh Y; Brucker S; Lang F; Brosens JJ
Cell Physiol Biochem; 2016; 39(5):2077-2087. PubMed ID: 27825168
[TBL] [Abstract][Full Text] [Related]
5. SGK1: The Dark Side of PI3K Signaling.
Di Cristofano A
Curr Top Dev Biol; 2017; 123():49-71. PubMed ID: 28236975
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the Ca(2+) channel TRPV6 by the kinases SGK1, PKB/Akt, and PIKfyve.
Sopjani M; Kunert A; Czarkowski K; Klaus F; Laufer J; Föller M; Lang F
J Membr Biol; 2010 Feb; 233(1-3):35-41. PubMed ID: 20041238
[TBL] [Abstract][Full Text] [Related]
7. PI3K Inhibition Activates SGK1 via a Feedback Loop to Promote Chromatin-Based Regulation of ER-Dependent Gene Expression.
Toska E; Castel P; Chhangawala S; Arruabarrena-Aristorena A; Chan C; Hristidis VC; Cocco E; Sallaku M; Xu G; Park J; Minuesa G; Shifman SG; Socci ND; Koche R; Leslie CS; Scaltriti M; Baselga J
Cell Rep; 2019 Apr; 27(1):294-306.e5. PubMed ID: 30943409
[TBL] [Abstract][Full Text] [Related]
8. RES-529: a PI3K/AKT/mTOR pathway inhibitor that dissociates the mTORC1 and mTORC2 complexes.
Weinberg MA
Anticancer Drugs; 2016 Jul; 27(6):475-87. PubMed ID: 26918392
[TBL] [Abstract][Full Text] [Related]
9. Feedback Activation of SGK3 and AKT Contributes to Rapamycin Resistance by Reactivating mTORC1/4EBP1 Axis via TSC2 in Breast Cancer.
Wang H; Huang F; Zhang Z; Wang P; Luo Y; Li H; Li N; Wang J; Zhou J; Wang Y; Li S
Int J Biol Sci; 2019; 15(5):929-941. PubMed ID: 31182914
[TBL] [Abstract][Full Text] [Related]
10. Serum- and Glucocorticoid-inducible Kinase 1 is Essential for Osteoclastogenesis and Promotes Breast Cancer Bone Metastasis.
Zhang Z; Xu Q; Song C; Mi B; Zhang H; Kang H; Liu H; Sun Y; Wang J; Lei Z; Guan H; Li F
Mol Cancer Ther; 2020 Feb; 19(2):650-660. PubMed ID: 31694887
[TBL] [Abstract][Full Text] [Related]
11. Protein kinase CK2 impairs spatial memory formation through differential cross talk with PI-3 kinase signaling: activation of Akt and inactivation of SGK1.
Chao CC; Ma YL; Lee EH
J Neurosci; 2007 Jun; 27(23):6243-8. PubMed ID: 17553997
[TBL] [Abstract][Full Text] [Related]
12. mTOR-raptor binds and activates SGK1 to regulate p27 phosphorylation.
Hong F; Larrea MD; Doughty C; Kwiatkowski DJ; Squillace R; Slingerland JM
Mol Cell; 2008 Jun; 30(6):701-11. PubMed ID: 18570873
[TBL] [Abstract][Full Text] [Related]
13. Coordinate expression of the PI3-kinase downstream effectors serum and glucocorticoid-induced kinase (SGK-1) and Akt-1 in human breast cancer.
Sahoo S; Brickley DR; Kocherginsky M; Conzen SD
Eur J Cancer; 2005 Nov; 41(17):2754-9. PubMed ID: 16246546
[TBL] [Abstract][Full Text] [Related]
14. Second AKT: the rise of SGK in cancer signalling.
Bruhn MA; Pearson RB; Hannan RD; Sheppard KE
Growth Factors; 2010 Dec; 28(6):394-408. PubMed ID: 20919962
[TBL] [Abstract][Full Text] [Related]
15. Remodeling mTORC1 Responsiveness to Amino Acids by the Herpes Simplex Virus UL46 and Us3 Gene Products Supports Replication during Nutrient Insufficiency.
Vink EI; Lee S; Smiley JR; Mohr I
J Virol; 2018 Dec; 92(24):. PubMed ID: 30282708
[TBL] [Abstract][Full Text] [Related]
16. A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas.
Beauchamp RL; James MF; DeSouza PA; Wagh V; Zhao WN; Jordan JT; Stemmer-Rachamimov A; Plotkin SR; Gusella JF; Haggarty SJ; Ramesh V
Oncotarget; 2015 Jul; 6(19):16981-97. PubMed ID: 26219339
[TBL] [Abstract][Full Text] [Related]
17. L6 myoblast differentiation is modulated by Cdk5 via the PI3K-AKT-p70S6K signaling pathway.
Sarker KP; Lee KY
Oncogene; 2004 Aug; 23(36):6064-70. PubMed ID: 15208659
[TBL] [Abstract][Full Text] [Related]
18. Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a).
Brunet A; Park J; Tran H; Hu LS; Hemmings BA; Greenberg ME
Mol Cell Biol; 2001 Feb; 21(3):952-65. PubMed ID: 11154281
[TBL] [Abstract][Full Text] [Related]
19. 17β-estradiol suppresses lipopolysaccharide-induced acute lung injury through PI3K/Akt/SGK1 mediated up-regulation of epithelial sodium channel (ENaC) in vivo and in vitro.
Qi D; He J; Wang D; Deng W; Zhao Y; Ye Y; Feng L
Respir Res; 2014 Dec; 15(1):159. PubMed ID: 25551628
[TBL] [Abstract][Full Text] [Related]
20. Discrete signaling mechanisms of mTORC1 and mTORC2: Connected yet apart in cellular and molecular aspects.
Jhanwar-Uniyal M; Amin AG; Cooper JB; Das K; Schmidt MH; Murali R
Adv Biol Regul; 2017 May; 64():39-48. PubMed ID: 28189457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]